Blog Posts
Major microbiome disruption and Toxicities Following Idecabtagene Vicleucel in Multiple Myeloma patients

Major microbiome disruption and Toxicities Following Idecabtagene Vicleucel in Multiple Myeloma patients

Muzaffar Qazilbash, Professor of Medicine at UT- MD Anderson Cancer Center, shared a post on X:

“Major microbiome disruption was associated with toxicities following ide-cel administration in patients with multiple myeloma.”

Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel

Authors: Satabdi Saha et al.

Idecabtagene Vicleucel

Abdur Rehman cancer Chia-Chi Chang Christine Peterson Christopher R. Flowers Donna M Weber Doris K. Hansen Elizabeth J. Shpall Faezeh Darbaniyan Frederick L. Locke Hans C. Lee idecabtagene vicleucel Krina K. Patel Lubna Rehman Mahmoud R Gaballa Marco L. Davila Mark R. Tanner Meghan Menges Melody Becnel Michael D. Jain Muzaffar Qazilbash Neeraj Y Saini OncoDaily Oncology Reetakshi Arora Robert R Jenq Robert Z. Orlowski Salvatore Corallo Satabdi Saha Sattva S. Neelapu Sheeba K. Thomas